Another example of the highly variable clinical course of recurrent/resistant/persistent ovarian cancer.
Markman
Maurie
M
D000230:Adenocarcinoma / Q000188:drug therapy*; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
D018906:Antineoplastic Agents, Alkylating; D007069:Ifosfamide